Mycobacterial Diseases

Mycobacterial Diseases
Open Access

ISSN: 2161-1068

+44 1478 350008

Research Article - (2014) Volume 4, Issue 3

Evaluation of Molecular Diversity of Mycobacterium tuberculosis Strains By Polymorphisms in RD Regions

Ehsan Sharifipour1, Mohammad Javad Nasiri1*, Parissa Farnia1, Mohadeseh Mozafari1, Shiva Irani2 and Ali Akbar Velayati1
1Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
*Corresponding Author: Mohammad Javad Nasiri, Mycobacteriology Research Centre, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, 19556, P.O: 19575/154, Iran, Tel: 98-21-29901 Email:

Abstract

Background: The region of differences (RDs) polymorphisms is a potential molecular epidemiology method to distinguish origins of Mycobacterium tuberculosis (MTB). Till date, 68 RDs were identified in MTB. This study was designed to investigate highly polymorphic regions (RD1, RD150 and RD181) among MTB strains isolates from Iranian Pulmonary tuberculosis patients (PTB).

Method and materials: A total of the 190 MTB isolates were identified by conventional and molecular methods. Thereafter, Spoligotyping and RD typing (RD1, RD150 and RD181) were applied to genotype these strains.

Results: The most frequent spoligotype belong to Haarlem (n=72, 37.8%) followed by CAS (n=37, 19.4%), T1 (n=18, 9.4%) and Beijing (n=11, 5.7%) lineages. Deletion in RD181 was only identified among Beijing lineage.

Conclusion: Deletion in RD181 was prominent among the prevalent Beijing strains in Iran. In this regard, this deletion marker can be used in identification, phylogeny, and molecular epidemiology of the Beijing genotype.

Keywords: Mycobacterium tuberculosis, Region of differences, Iran

Introduction

Tuberculosis (TB) is recognized as a major public health problem in nearly all parts of the world. According to the World Health Organization (WHO), among 8.7 million incident case of TB in year 2011, 7.7% occurred in the Eastern Mediterranean Region [1]. Iran is among the leading countries in implementation of DOTS strategies in this region and has a moderate incidence of TB (21 cases per 100’000 population) [2]. However, bordering with high-TB burden countries (Afghanistan and Pakistan) and increasing rates of drug resistance TB, threaten the control strategies [3,4].

Since the discovery of polymorphic DNA, molecular typing of Mycobacterium tuberculosis (MTB) strains has become a valuable tool for control of disease. Until now, several genotyping methods for MTB strains exist, of which IS6110-restriction fragment length polymorphism (RFLP), spoligotyping and variable number tandem repeat (VNTR) were among the most commonly used [5,6]. Recently, MTB strains were identified by a number of insertion or deletion events in specific genomic regions known as regions of differences (RDs) [7,8]. Among these RDs, deletions in RD1, RD150 and RD181 were mostly associated with drug resistant strains i.e. Beijing linage strains [9]. Previously, the association between these set of RDs deletions and a family of MTB strains have been reported by several studies [9-12]. However, whether these regions have an epidemiological significance remains to be investigated. Therefore, this study was designed to determine the frequency of RD deletions in a collection of MTB strains in Iran and to examine the potential power of these RDs for genotyping analysis.

Materials and Methods

Setting and study population

This study was conducted over a one year of period (from March 2011 to February 2012) in the only national TB center in Iran. The study was cross-sectional that was performed single blinded. A total of 190 patients with clinical signs and symptoms of TB (107 male and 83 female) were included in the study after a signed informed consent. This survey was approved by the local Ethics Committee.

Isolation of MTB

Samples from each patient were decontaminated by Petroff’s method and were inoculated into Lowenstein-Jensen (LJ) media (Merck) [13]. The slope cultures were incubated at 37°C and examined for growth once weekly up to 6 weeks. Each isolate was examined regarding morphology, pigmentation and date of growth. Bacterial isolates identified as MTB complex using standard spoligotyping analysis [6,14].

Drug susceptibility testing

Drug susceptibility was determined by the proportion method on Lowenstein-Jensen medium using the critical concentrations for RMP (40 μg/ml), INH (0.2 μg/ml), ethambutol (EMB) (2 μg/ml) [15].

DNA extraction

QIAGEN DNA extraction kit was used for DNA extraction with the manual procedure recommended in kit [16]. Quality and quantity of DNA was obtained with Picodrop spectrometer.

Spoligotyping

Spoligotyping was performed for all MTB isolates as previously described [6]. Template DNA was amplified by PCR using specific primers as described by Kemerbeek et al. [6]. The PCR product was hybridized to 43 immobilized oligonucleotides derived from the spacer sequences of MTB H37Rv and M.bovis BCG P3. Presence of spacer sequences in the direct repeat region was detected by reversedline blot hybridization. Hybridized DNA was detected by enhanced chemiluminesence (ECL, Amersham, UK) and by exposing ECL-Hyper film (Amersham). The obtained spoligo patterns were compared with the SPOLB4 Database.

Determination of RD deletions

Extracted DNA was amplified by PCR using the primers indicated in Table 1. The target DNA was amplified in a 50 μl mixture containing 1× reaction buffer (50 mM KCl, 10 mM Tris-HCl (pH 9.0), 2 mM MgCl2), 2.5 mM of dNTPs, 2U of Taq DNA-polymerase (mi Taq, Metabion, Martinsried, Germany), and 20 pmol of each primers. Amplification was performed in an automated thermal cycler (Eppendorf, Germany) with the following conditions: Initial denaturation at 95°C for 3min, followed by 40 cycles of denaturation for 30 sec at 94°C, annealing for 1 min at 65°C, and extension for 90 sec at 72°C and an additional extension step at 72°C for 10 min. The PCR products were electrophoresed in 1.5% agarose gels and visualized in a UV Trans illuminator.

Locus Primers PCR Product size References
RD1 ET1: 5’AAG CGG TTG CCG CCG ACC GAC C 3’
ET2: 5’CTG GCT ATA TTC CTG GGC CCG G3’
ET3: 5’GAG GCG ATC TGG CGG TTT GGG G3’
1.5kb Kanji et al [20]
RD150 F: 5’TGT GGC GTG GCT CGG CAA ATA G3’
R: 5’CGG GAC GGC AAA CGG GTG AT3’
2.5kb Tsolaki et al [9]
RD181 F: 5’CGC AAC GGC CGC GGT GAA CTC T3’
R: 5’CGG GCG GCT GCG GGA ACC TT3’
0.7kb Tsolaki et al [9]

Table 1: Primer Sequences for the detection of RD1, RD150 and RD181.

Statistical analysis

Statistical analysis was carried out using SPSS statistical software, version 18 (SPSS Inc., Chicago, IL, USA).

Results

Drug susceptibility testing

Of 190 MTB isolates for whom drug susceptibility testing was performed, 30 (16%) were multidrug resistance (MDR), 12 (7%) were isoniazid (INH) resistant, 8 (4%) were ethambutol (EMB) resistant and 5 (3%) were rifampicin (RMP) resistant. The remaining 135 (70%) isolates were pan-susceptible.

Spoligotyping

According to the spoligotyping patterns, 138 (73%) isolates were classified as shared types according to international database. The remaining 52 (27%) isolates generated unknown spoligopatterns. As shown in Table 2, H4 (37.8%) family was the most prevalent spoligotype followed by CAS (19.4%), T1 (9.4%) and Beijing (5.7%) strains. Out of 11 Beijing strain lineages analyzed in the current study, 55% were susceptible to the mentioned drugs and 36% were MDR (Table 3).

Frequency Genetic group Spoligo pattern Strain
72 (37.8%) 2,3 image H4
37 (19.4%) 1 image CAS
18 (9.4%) 2,3 image T1
11 (5.7%) 1 image Beijing
52 (27.3%) -   Unknown
190 (100%) -   Total

Table 2: The spoligotyping pattern of MTB strains.

Families Susceptible MDR INH ETB RF Total
H4 64 (88%) 3 (4.5%) 2 (3%) - 3 (4.5%) 72 (100)
CAS 29 (76%) 3 (9%) 3 (9%) 1 (3%) 1 (3%) 37 (100)
T1 14 (78.5%) 3 (14%) 1 (7.5%) - - 18 (100)
Beijing 6 (55%) 4 (36%) 1 (9%) - - 11(100)
Unknown 25 (47.5%) 6 (10.5%) 11 (21%) 5 (10.5%) 5 (10.5%) 52 (100)

Table 3: Drug resistant patterns of MTB strain.

RD deletions in different MTB spoligotypes

As shown in Figure 1, RD PCR results showed no discriminative diversity in locus RD1. The genomic allelic diversity in RD181 region was only discriminative in 11 samples which all were Beijing. Results are mentioned in Figure 2. Furthermore no discriminative allelic diversity in genomic region of RD150 was observed. The spoligotypes and distribution of RD deletions in the RD1, RD150 and RD181 regions were determined for all studied strains (Table 4).

mycobacterial-diseases-Electrophoresis-fractionation

Figure 1: Electrophoresis fractionation of PCR products in 3% agarose gel regarding existing deletion in RD1. The deletion can well be observed in BCG. Molecular weight marker (100 bp ladder) was used for RD1.

mycobacterial-diseases-PCR-products

Figure 2: Electrophoresis fractionation of PCR products in 1% Agarose gel to detect existing deletion in RD181. The deletion can be diagnosed in the genomic region of RD181 in Beijing strains. PCR products molecular weight was 1000 bp. Molecular weight marker (100 bp ladder) was used.

Strain Locus RD1 RD181 RD150
H4 - - -
CAS - - -
T1 - - -
Beijing - 100%* -
*RD181 deletion was found in all Beijing strains

Table 4: RD1, RD150 and RD181 deletions in MTB strains.

Discussion

RDs have been described in numerous surveys as important markers for molecular epidemiology of TB [9]. The present study was aimed to explore the epidemiological significance of highly polymorphic regions (RD1, RD150 and RD181) among MTB strains.

Based on SIT from SITVIT2, the major identified isolates of MTB were characterized with Haarlem (n=72, 37.8%), CAS (n=37, 19.4%), T (n=18, 9.4%) and Beijing (n=11, 5.7%) lineages (Table 2). These strains have also been described as the most prevalent MTB families in Iran [17-19].

Recently, it was shown that deletions in specific RDs are significantly associated with particular genotypes of MTB. Kanji et al. showed that deletions in the CAS lineages were limited to RD149, RD152 and RD750 [20]. They also suggested that strains with these kinds of deletions are a prominent cause of TB among Asians ethnics. Furthermore, deletion in RD750 appears to have increased the capacity of CAS genotypes to disturb immune responses and contribute to its persistence in host [20,21]. In the case of Beijing lineage, it was reported that patients infected by Beijing subtype with simultaneous deletions of RD150 and RD181 were more likely to develop severe form of TB [22]. Similarly, in the survey conducted by Tsolaki et al., deletion in RD105, RD142, RD150 and RD181 was significantly associated with Beijing genotypes [9]. In our study, only RD181 deletion was found in all the Beijing strains and was highly discriminative (Table 4). Indeed, the lack of association between Beijing strains and other RD regions (i.e. RD 150) could be explained by the small number of Beijing samples analyzed in this study. The Beijing family was first identified in 1995 as a closely related group of tubercle bacilli in China, but soon after they have been described by many countries throughout the world [23-26]. Likewise, the prevalence of Beijing family in Iran showed a significant increase in recent years [17,27]. According to the Farnia et al., the Beijing strains were among the major identified super families in Iran [17]. Furthermore, they indicated that more that 50% of the Beijing genotypes were isolated from Afghans and there was a linkage patterns between these cases and Iranian patients. This lineage has also been shown as one of the predominant strain in the Asian countries where TB is endemic, i.e. Afghanistan and Pakistan. These countries shares long geographical borders with Iran and its ethnic groups frequently move inside the borders of Iran [28]. Consequently, long borders and frequent movement of ethnic groups may be one of the factors to explain the increasing prevalence of the Beijing super family in Iran. In the other hand, Beijing lineage strains have been found to be associated with severe form of disease, global transmission and drug resistance [4,22]. Therefore, early diagnosis of this kind of strains is one of the most important priorities for TB control strategies. Our result indicated that RD181 deletion can be a useful marker for detection of the Beijing lineage strain. In addition, Beijing families can easily be identified by RD assay (a PCR-based method) as compared with spoligotyping.

In conclusion, deletion in RD181 was prominent among the prevalent Beijing strains in Iran. In this regard, this deletion marker can be used in identification, phylogeny, and molecular epidemiology of the Beijing genotype. However, further analysis with large number of strains would be necessary to elucidate the discriminative power of these genetic regions in M. tuberculosis genotyping.

Acknowledgements

The study was supported by National Research Institute of Tuberculosis and Lung Disease-Tehran-Iran.

References

  1. Velayati AA, Farnia P, Masjedi MR. (2012)Pili in totally drug resistant Mycobacterium Tuberculosis (TDR-TB). International Journal of Mycobacteriology 1: 57-58.
  2. Hoffner SE (2001)The role of drug susceptibility testing in M/XDR-TB. Too little and too late–Are we doing the right things. International Journal of Mycobacteriology 2: 191-193.
  3. Van Embden J, Cave MD, Crawford JT, Dale J, Eisenach K, et al. (1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. Journal of clinical microbiology 31: 406-409.
  4. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J ClinMicrobiol 35: 907-914.
  5. Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, et al. (1999) Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. MolMicrobiol 32: 643-655.
  6. Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, et al. (2002) A new evolutionary scenario for the Mycobacterium tuberculosis complex. ProcNatlAcad Sci U S A 99: 3684-3689.
  7. Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere YO, Kreiswirth BN, et al. (2005) Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J ClinMicrobiol 43: 3185-3191.
  8. Fleischmann R, Alland D, Eisen J, Carpenter L, White O, et al. (2002) Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. Journal of bacteriology 184: 5479-5490.
  9. Parsons LM, Brosch R, Cole ST, Somoskövi Á, Loder A, et al. (2002) Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. Journal of clinical microbiology 40: 2339-2345.
  10. Rao KR, Kauser F, Srinivas S, Zanetti S, Sechi LA, et al. (2005) Analysis of genomic downsizing on the basis of region-of-difference polymorphism profiling of Mycobacterium tuberculosis patient isolates reveals geographic partitioning. Journal of clinical microbiology 43: 5978-5982.
  11. Petroff SA (1915) A New and Rapid Method for the Isolation and Cultivation of Tubercle Bacilli Directly from the Sputum and Feces. J Exp Med 21: 38-42.
  12. Velayati AA, Farnia P, Mozafari M, Sheikholeslami MF, Karahrudi MA, et al. (2014) High Prevelance of Rifampin-Monoresistant Tuberculosis: A Retrospective Analysis among Iranian Pulmonary Tuberculosis Patients. The American journal of tropical medicine and hygiene 90: 99.
  13. Rieder HL, Chonde TM, Myking H, Urbanczik R, Laszlo A, et al. (1998) The public health service national tuberculosis reference laboratory and the national laboratory network; minimum requirements, role and operation in a low-income country. International Union against Tuberculosis and Lung Disease (IUATLD).
  14. Hosek J, Svastova P, Moravkova M, Pavlik I, Bartos M (2006) Methods of mycobacterial DNA isolation from different biological material: a review. Veterinarnimedicina 51: 180-192.
  15. Farnia P, Masjedi MR, Mirsaeidi M, Mohammadi F, Jallaledin-Ghanavi, et al. (2006) Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients. J Infect 53: 331-336.
  16. Rohani M, Farnia P, Nasab MN, Moniri R, Torfeh M, et al. (2009) Beijing genotype and other predominant Mycobacterium tuberculosis spoligotypes observed in Mashhad city, Iran. Indian journal of medical microbiology 27: 306.
  17. Farnia P, Mohammadi F, Masjedi MR, Varnerot A, Zarifi AZ, et al. (2004) Evaluation of tuberculosis transmission in Tehran: using RFLP and spoligotyping methods. J Infect 49: 94-101.
  18. Kanji A, Hasan Z, Tanveer M, Laiq R, Hasan R (2011) Occurrence of RD149 and RD152 deletions in Mycobacterium tuberculosis strains from Pakistan. J Infect DevCtries 5: 106-113.
  19. Newton SM, Smith RJ, Wilkinson KA, Nicol MP, Garton NJ, et al. (2006) A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proceedings of the national academy of Sciences 103: 15594-15598.
  20. Kong Y, Cave M, Zhang L, Foxman B, Marrs C, et al. (2006) Population-based study of deletions in five different genomic regions of Mycobacterium tuberculosis and possible clinical relevance of the deletions. Journal of clinical microbiology 44: 3940-3946.
  21. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D (2002) Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 8: 843-849.
  22. Parwati I, van Crevel R, van Soolingen D (2010) Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. The Lancet infectious diseases 10: 103-111.
  23. Tanveer M, Hasan Z, Siddiqui AR, Ali A, Kanji A, et al. (2008) Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC Infect Dis 8: 171.
  24. Kisa O, Tarhan G, Gunal S, Albay A, Durmaz R, et al. (2012) Distribution of spoligotyping defined genotypic lineages among drug-resistant mycobacterium tuberculosis complex clinical isolates in ankara, turkey. PloS one 7: e30331.
  25. Ramazanzadeh R,Sayhemiri K (2014) Prevalence of Beijing family in Mycobacterium tuberculosis in world population: Systematic Review and Meta-Analysis. International Journal of Mycobacteriology 3: 41-45.
  26. Nasiri MJ, Rezaei F, Zamani S, Darban-Sarokhalil D, Fooladi AA, et al. (2014) Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran. Asian Pac J Trop Med 7: 193-196.
Citation: Sharifipour E, Nasiri MJ, Farnia P, Mozafari M, Irani S, et al. (2014) Evaluation of Molecular Diversity of Mycobacterium tuberculosis Strains By Polymorphisms in RD Regions. J Mycobac Dis 4:153.

Copyright: © 2014 Sharifipour E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top